Fused quinoline derivative and use thereof
Details for Australian Patent Application No. 2005238388 (hide)
International Classifications
Event Publications
16 November 2006 PCT application entered the National Phase
PCT publication WO2005/105802 Priority application(s): WO2005/105802
25 August 2011 Application Accepted
Published as AU-B-2005238388
19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005238386-Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser